Comparison of Recombinant Human Erytropoetin and Darbepoetin Alpha in Children

ConclusionDA therapy can be an alternative to rHuEPO in the treatment of anemia in pediatric CKD patients with its clinical efficacy, application convenience, patient compliance and tolerability.

Source: Pediatrics International - March 5, 2013 Category: Pediatrics Authors: Ceren Can, Sevinç Emre, Ilmay Bilge, Alev Yilmaz, Aydan Şirin Tags: Original Article Source Type: research